Concurrent Investment Advisors »

Marker Therapeutics shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $100k 68k 1.47

More positions owned by Concurrent Investment Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Call Option (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation Call Option (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon Call Option (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Call Option (AVGO)
Vanguard Index Fds Total Stk Mkt (VTI)
Micron Technology (MU)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Concurrent Investment Advisors

Top funds holding Marker Therapeutics

NEA Management Company
Blue Owl Capital Holdings
Vanguard Capital Management
Aisling Capital Management
Renaissance Technologies
Geode Capital Management
Advisor Group Holdings
Vanguard Fiduciary Trust
LPL Financial
Concurrent Investment Advisors
Two Sigma Investments
XTX Topco
Northern Trust
Citadel Advisors
State Street Corporation

View all funds holding Marker Therapeutics